> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Senate Subcommittee Gives FDA $200 Million Budget Boost
- URL: https://www.fdaweb.com/senate-subcommittee-gives-fda-200-million-budget-boost/
- Published: 2021-08-03T12:00:00.000Z
- Updated: 2026-09-14T17:08:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149855

A Senate appropriations subcommittee has voted to advance FDA’s fiscal year 2022 budget that would give the agency a $200 million (6%) spending boost. The subcommittee approved FDA’s total funding at $3.414 billion, which (XXX SPELLING XXprovides increases for food (XXX DELETE XXand medical product safety activities.

The spending measure would provide an increase of $15 million to enhance inspections of facilities under FDA’s jurisdiction.“ An increase of $14 million is included for maternal and infant health to work on toxic elements in baby food,” a [subcommittee release](https://www.appropriations.senate.gov/news/majority?ref=fdaweb.com) says. “To continue the work the agency is doing to address the opioid crisis, the bill includes an increase of $24 million for international mail facilities for a total of $62 million.” Additionally, the members increased FDA sending on information technology by $25 million.  

The Alliance for a Stronger FDA had this to say in reaction to the spending bill: “The subcommittee mark represents a strong commitment by the Senate to FDA’s resource needs and is consistent with the Alliance’s FY 22 request that FDA receive no less than a $200 million increase in BA funding. The Senate subcommittee started with a significantly lower budget allocation than the House. However, both bodies chose to provide slightly more than 13% of their available funds to FDA.”

In contrast, the House has approved $3.471 billion in discretionary funding in its bill, an increase of $257 million (8%) above the FY 2021 enacted level. “Total funding for FDA, including revenue from user fees, is $6.288 billion,” a [House committee notice](https://appropriations.house.gov/news/press-releases/appropriations-subcommittee-approves-fiscal-year-2022-agriculture-rural?ref=fdaweb.com) says. “Within this total, the committee provides a targeted increase of $72 million to address the opioid crisis, medical supply chain surveillance, rare cancers, and increasing and strengthening inspections. It also includes a $65 million increase to better avoid or more quickly respond to food outbreaks, improve the animal food inspection system, and addresses heavy metals in baby food. The bill also appropriates $50 million to accelerate medical product development as authorized in the 21st Century Cures Act.”

The Senate measure is expected to be marked up by the full committee on 8/4.